Select Medical Holdings

Select Medical Holdings Corp. engages in the provision of medical rehabilitation services. It operates through the following segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation and Concentra. The Critical Illness Recovery Hospital segment serves patients with debilitating injuries and rehabilitation needs that cannot be adequately cared in a medically intensive environment, such as a skilled nursing facility. The Rehabilitation Hospital segment provides physical medicine, as well as rehabilitation programs and services, which serve to optimize patient health, function, and quality of life. The Outpatient Rehabilitation segment provides physical, occupational, and speech rehabilitation services through its clinics. The Concentra segment operates through its medical centers and contract services provided at employer worksites and Department of Veterans Affairs community-based outpatient clinics, which deliver occupational medicine, physical therapy, veteran’s healthcare, and consumer health services. The company was founded by Robert A. Ortenzio and Rocco A. Ortenzio in 1996 and is headquartered in Mechanicsburg, PA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Select Medical Holdings reports strong Q4 results and growth outlook

Select Medical Holdings demonstrated financial strength and growth potential in Q4 2022 across its divisions.
While challenges like labor market uncertainty persist, opportunities for revenue growth and strategic expansion are evident.
The company's focus on cost management and operational efficiency bodes well for future performance and stakeholder engagement.

Select Medical Holdings posts strong Q1 results, eyes growth

Select Medical Holdings (SEM) reported robust Q1 2023 results, showcasing growth across all divisions and a positive outlook for the year ahead.
The company's focus on cost management, strategic investments, and operational efficiency positions it well for continued success and market expansion.
While facing challenges such as revenue fluctuations and rising interest expenses, Select Medical Holdings remains proactive in addressing operational and financial hurdles.
Opportunities for growth through market expansion, technology utilization, and strategic initiatives underscore a promising trajectory for the company.

Select Medical Holdings reports strong Q2 performance and growth outlook

Select Medical Holdings (SEM) demonstrated robust financial performance in Q2 2023, driven by revenue growth and improved EBITDA across divisions.
The company's strategic refinancing and positive industry recognition position SEM well for future growth and operational excellence.
While facing challenges in maintaining exceptional growth rates, SEM has opportunities to capitalize on its strengths and market positioning for sustained success.

Select Medical Holdings (SEM) reports strong Q3 performance and expansion plans

Select Medical Holdings (SEM) demonstrated robust financial growth in Q3 2023, driven by improvements in various divisions.
The company's focus on expansion through new hospital openings and partnerships presents promising opportunities for future growth.
Overall, Select Medical Holdings (SEM) is well-positioned for continued success and value creation for its shareholders.

Select Medical Holdings reports strong Q4 results and growth opportunities

SEM's strong performance in Q4 2023 and strategic initiatives position the company for growth and value creation.
While facing challenges such as projected start-up losses and increased interest expenses, SEM is actively pursuing opportunities for financial optimization.
The company's focus on separating Concentra, expanding partnerships, and managing capital allocation underscores its commitment to enhancing shareholder value.
Investors should monitor SEM's progress in executing its 2024 outlook and addressing financial challenges to assess future performance.

Select Medical Holdings posts robust Q1 results and outlines growth plans

Select Medical Holdings (SEM) reported strong financial and operational performance in Q1 2024, driven by revenue growth, margin expansion, and strategic initiatives.
While facing challenges in working capital management and capital allocation decisions, SEM's focus on efficiency and growth presents opportunities for value creation and market expansion.
Investors should monitor SEM's progress in executing its growth plans, managing debt levels, and capitalizing on opportunities in the healthcare services sector.

Select Medical Holdings reports solid Q2 performance and expansion plans

Select Medical Holdings delivered a strong Q2 performance with revenue and EBITDA growth across key divisions.
The company's focus on expansion, quality healthcare services, and shareholder returns positions it well for future growth.
While facing challenges like earnings per share decline and regulatory changes, Select Medical has opportunities for market expansion and service enhancement.
Investors should monitor Concentra's performance details and the company's strategic execution in new hospital developments.

Select Medical Holdings reports strong Q3 performance and expansion plans

Select Medical Holdings delivered a robust performance in Q3, with strong revenue and EBITDA growth across all divisions.
The company's expansion plans and strategic projects indicate a focus on long-term growth and market presence.
While facing challenges in managing expansion and financing, Select Medical has opportunities to capitalize on sector growth and operational improvements.
Investors can be optimistic about Select Medical's financial health, demonstrated by the declared cash dividend and positive performance indicators.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Select Medical Holdings Corp. engages in the provision of medical rehabilitation services. It operates through the following business segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation and Concentra. The Critical Illness Recovery Hospital segment serves patients with debilitating injuries and rehabilitation needs that cannot be adequately cared for in a medically intensive environment, such as a skilled nursing facility. The Rehabilitation Hospital segment provides physical medicine, as well as rehabilitation programs and services, which serve to optimize patient health, function, and quality of life. The Outpatient Rehabilitation segment offers physical, occupational, and speech rehabilitation services through its clinics. The Concentra segment operates through its medical centers and contract services provided at employer worksites and Department of Veterans Affairs community-based outpatient clinics, which deliver occupational medicine, physical therapy, veteran’s healthcare, and consumer health services. The company was founded by Robert A. Ortenzio and Rocco A. Ortenzio in 1996 and is headquartered in Mechanicsburg, PA.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Are Investors Undervaluing Select Medical (SEM) Right Now?

Azenta

Concentra Group Holdings Parent Inc

Envestnet

Flex

Myers

NEW YORK , Nov. 19, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600: Flex Ltd (NASD: FLEX) will replace Azenta Inc. (NASD: AZTA) in the S&P MidCap 400, and Azenta will replace Envestnet Inc. (NYSE: ENV) in the S&P SmallCap 600 effective prior to the opening of trading on Monday, November 25. Bain Capital is acquiring Envestnet in a deal expected to be completed soon, pending final closing conditions.

Flex Set to Join S&P MidCap 400; Azenta and Concentra Group Holdings to Join S&P SmallCap 600

MECHANICSBURG, Pa. , Nov. 19, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE: SEM) today announced the distribution ratio for the previously announced special stock distribution (the "Distribution") to its stockholders of its equity interest in Concentra Group Holdings Parent, Inc. ("Concentra") (NYSE: CON).

Select Medical Holdings Corporation Announces Distribution Ratio for Special Stock Distribution to Stockholders

MECHANICSBURG, Pa.  , Nov. 18, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Holdings") (NYSE: SEM), today announced that Select Medical Corporation, a wholly-owned subsidiary of Holdings ("Select"), has priced a private offering (the "Offering") of $550.0 million in aggregate principal amount of its 6.250% senior notes due 2032 (the "notes").

Select Medical Holdings Corporation Announces Pricing of Offering of 6.250% Senior Notes due 2032 by Select Medical Corporation

MECHANICSBURG, Pa. , Nov. 18, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Holdings") (NYSE: SEM), today announced that Select Medical Corporation ("Select") has commenced a private offering (the "Offering"), subject to market and other customary conditions, of $850 million in aggregate principal amount of senior notes due 2032 (the "notes").

Select Medical Holdings Corporation Announces Offering of $850 Million of Senior Notes by Select Medical Corporation

On November 06, Select Medical Holdings (NYSE: SEM; $40.20; Market Cap: $5.2 billion) announced a special stock distribution of its carved out unit Concentra Holdings (NYSE: CON; $19.67; Market Cap: $2.5 billion) to its shareholders. The distribution is set for November 25, 2024, with a record date of November 18, 2024.

Select Medical To Spin-Off Concentra On November 25th

MECHANICSBURG, Pa. , Nov. 6, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE: SEM) today announced that its Board of Directors has approved a special stock distribution (the "Distribution") to Select Medical's stockholders of the 104,093,503 shares of common stock of Concentra Group Holdings Parent, Inc. ("Concentra") (NYSE: CON) owned by Select Medical Corporation ("SMC"), a wholly owned subsidiary of Select Medical, representing approximately 81.7% of the outstanding shares of Concentra's common stock.

Select Medical Holdings Corporation Announces Declaration of a Special Stock Distribution to Spin-Off Concentra

SEM's strong third-quarter results benefit from improving patient days and admissions in the Rehabilitation Hospital segment. Elevated expenses partially offset the positives.

Select Medical Up 13.8% Since Q3 Earnings Top on Patient Day Growth

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Here's Why Select Medical (SEM) is a Strong Momentum Stock

Select Medical Holdings Corporation (NYSE:SEM ) Q3 2024 Results Earnings Conference Call November 1, 2024 9:00 AM ET Company Participants Robert Ortenzio - Executive Chairman and Co-Founder Martin Jackson - Senior Executive Vice President of Strategic Finance and Operations Conference Call Participants Ben Hendrix - RBC Capital Markets Justin Bowers - Deutsche Bank William Sutherland - The Benchmark Company Christian Malachy Porter - Bank of America Securities Operator Good morning, and thank you for joining us today for Select Medical Holdings Corporation's Earnings Conference Call to Discuss the Third Quarter 2024 Results and the Company's Business Outlook. Speaking today are the company's Executive Chairman and Co-Founder, Robert Ortenzio, and the company's Senior Executive Vice President of Strategic Finance and Operations, Martin Jackson.

Select Medical Holdings Corporation (SEM) Q3 2024 Earnings Call Transcript

Select Medical (SEM) came out with quarterly earnings of $0.50 per share, beating the Zacks Consensus Estimate of $0.36 per share. This compares to earnings of $0.46 per share a year ago.

Select Medical (SEM) Q3 Earnings and Revenues Surpass Estimates

MECHANICSBURG, Pa. , Oct. 31, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE: SEM) today announced results for its third quarter ended September 30, 2024, and the declaration of a cash dividend.

Select Medical Holdings Corporation Announces Results For Its Third Quarter Ended September 30, 2024 and Cash Dividend

New SSM Health Rehabilitation Hospital will open in December 2024 MECHANICSBURG, Pa. and OKLAHOMA CITY , Oct. 17, 2024 /PRNewswire/ -- Select Medical Corporation ("Select Medical") and SSM Health today announced the formation of a joint venture partnership to own and operate a 50-bed inpatient rehabilitation hospital in Oklahoma City to be named SSM Health Rehabilitation Hospital – Oklahoma City.

SELECT MEDICAL AND SSM HEALTH FORM JOINT VENTURE PARTNERSHIP TO OPERATE INPATIENT REHABILITATION HOSPITAL IN OKLAHOMA CITY

Select Medical Holdings has shown strong performance, with shares up 48.7% since October 2023, outperforming the S&P 500's 37.3% increase. The company operates in a growing healthcare sector, with consistent revenue and profit growth across its Critical Illness Recovery, Rehabilitation, Outpatient Rehabilitation, and Concentra segments. Despite significant stock price appreciation, Select Medical Holdings remains attractively priced compared to similar businesses, justifying a continued 'buy' rating.

Select Medical Holdings: No Reason To Downgrade This One Just Yet

MECHANICSBURG, Pa. , Oct. 1, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM), will release the financial results for its third quarter ended September 30, 2024 on Thursday, October 31, 2024 after the market closes.

Select Medical Holdings Corporation to Announce Third Quarter 2024 Results on Thursday, October 31, 2024

SEM's profitability is being impacted by rising costs and expenses.

Select Medical Rises 50.2% YTD: Take Profits or Bet on More Gains?

SEM enters a definitive agreement to acquire Valir Rehabilitation Hospital and expand its inpatient rehabilitation footprint in Oklahoma City.

Select Medical Agrees to Acquire Valir Rehabilitation Hospital

MECHANICSBURG, Pa. , Sept. 4, 2024 /PRNewswire/ -- Select Medical Corporation ("Select Medical") today announced the signing of a definitive agreement to purchase Valir Rehabilitation Hospital, a 50-bed inpatient rehabilitation facility in Oklahoma City, from Valir Health.

Select Medical to Acquire Oklahoma-based Valir Rehabilitation Hospital

Select Medical (SEM) expects its adjusted EBITDA between $845 million and $885 million for 2024, the mid-point of which implies a 7.1% rise from the 2023 reported figure of $807.4 million.

Select Medical's (SEM) Stock Down 16.9% Despite Q2 Earnings Beat

Select Medical Holdings Corporation (NYSE:SEM ) Q2 2024 Earnings Call Transcript August 2, 2024 9:00 AM ET Company Participants Robert Ortenzio - Executive Chairman & Co-Founder Martin Jackson - Senior EVP of Strategic Finance and Operations Conference Call Participants Ben Hendrix - RBC Capital Markets A.J. Rice - UBS Operator Good morning, and thank you for joining us today for Select Medical Holdings Corporation's earnings conference call to discuss the second quarter 2024 results and the Company's business outlook.

Select Medical Holdings Corporation (SEM) Q2 2024 Earnings Call Transcript

Select Medical (SEM) came out with quarterly earnings of $0.60 per share, beating the Zacks Consensus Estimate of $0.59 per share. This compares to earnings of $0.61 per share a year ago.

Select Medical (SEM) Q2 Earnings and Revenues Top Estimates

MECHANICSBURG, Pa. , Aug. 1, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE: SEM) today announced results for its second quarter ended June 30, 2024, and the declaration of a cash dividend.

Select Medical Holdings Corporation Announces Results For Its Second Quarter Ended June 30, 2024 and Cash Dividend

MECHANICSBURG, Pa., and LOS ANGELES , July 31, 2024 /PRNewswire/ -- Select Medical and Cedars-Sinai today announced the launch of a specialized spine care program for patients with acute or chronic spine conditions.

SELECT MEDICAL AND CEDARS-SINAI LAUNCH SPECIALIZED SPINE CARE PROGRAM IN GREATER LOS ANGELES REGION

Is Select Medical (SEM) Stock Undervalued Right Now?

MECHANICSBURG, Pa. and ADDISON, Texas, July 24, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM) and Concentra Group Holdings Parent, Inc. ("Concentra") (NYSE: CON), a wholly owned subsidiary of Select Medical, today announced the pricing of Concentra's initial public offering ("IPO") of 22,500,000 shares of Concentra's common stock at a price to the public of $23.50 per share.

News for Select Medical Holdings Stock (SEM)